CLPTM1
Summary:
| Name | OMIM ID | Ensembl ID | HGNC ID | PHARMGKB ID | Map Location |
|---|---|---|---|---|---|
| CLPTM1, transmembrane protein | MIM:604783 | Ensembl:ENSG00000104853 | HGNC:HGNC:2087 | PA26613 | 19q13.32 |
GO terms in CLPTM1
| Term Type | Evidence Type | GO Term ID | GO Des. |
|---|---|---|---|
| CC | TAS | GO:0005887 | integral component of plasma membrane |
| CC | ISS | GO:0009897 | external side of plasma membrane |
| CC | HDA | GO:0016020 | membrane |
| BP | IEA | GO:0007275 | multicellular organism development |
| BP | IEA | GO:0030154 | cell differentiation |
| BP | ISS | GO:0033081 | regulation of T cell differentiation in thymus |
| MF | IPI | GO:0005515 | protein binding |
Gene expression in normal tissue: CLPTM1
Gene-model tissue-cancer distribution: Bubble Plot
Gene-drug pathway distribution
Pathways in CLPTM1
| Database | Pathway ID | Pathway Des. |
|---|
Gene-Drug: Aster Plot
| Drug ID | Drug Name | Model Num. |
|---|---|---|
| iGMDRD188 | Piperlongumine | 2 |
| iGMDRD100 | Zebularine | 5 |
| iGMDRD399 | Selumetinib | 1 |
| iGMDRD451 | Serdemetan | 3 |
| iGMDRD886 | Compound 1541A | 2 |
| iGMDRD64 | Parbendazole | 2 |
| iGMDRD513 | BML-259 | 2 |
| iGMDRD121 | GMX1778 | 3 |
| iGMDRD870 | BRD63610 | 2 |
| iGMDRD187 | BRD9876 | 1 |
| iGMDRD351 | GW843682X | 2 |
| iGMDRD61 | Kinetin riboside | 3 |
| iGMDRD193 | Fqi1 | 2 |
| iGMDRD446 | LY 2183240 | 2 |
| iGMDRD123 | Isoevodiamine | 2 |
| iGMDRD280 | CYTOCHALASIN B | 1 |
| iGMDRD512 | nutlin 3 | 2 |
| iGMDRD1008 | SR-II-138A | 2 |
| iGMDRD84 | Lovastatin acid | 2 |
| iGMDRD546 | BMS-754807 | 2 |
Gene in drug-gene network: Network Plot
Gene-drug targets distribution
Gene Structure: PDB
Models in CLPTM1
CLASSFICATION
Copyright © 2018 Modellab | All Rights Reserved
Disclaimer: iGMDR is intended for research purposes only. Its information cannot be used for emergencies or medical or professional advice.